Cabergoline Tablets IP 0.5 Mg - CABRILAC 0.5 Tablets

CABRILAC 0.5 Tablets
Composition:- Cabergoline 0.5 mg

CABRILAC 0.5 Tablets – Cabergoline Tablets IP 0.5 Mg is a potent ergot-derived dopamine receptor agonist used in the management of hyperprolactinemia and associated reproductive disorders. By selectively stimulating dopamine D2 receptors in the pituitary, it effectively inhibits prolactin secretion, helping to restore normal hormone levels. Cabergoline offers a longer duration of action and better tolerability compared to bromocriptine, allowing convenient once- or twice-weekly dosing. It has demonstrated significant efficacy in treating hyperprolactinemia-related infertility and in managing micro- and macroadenomas, providing effective therapeutic outcomes with minimal side effects.

Key Points of Cabergoline Tablets IP 0.5 Mg – CABRILAC 0.5 Tablets
• Potent Dopamine D2 Agonist: Strongly inhibits prolactin secretion at the pituitary, providing sustained therapeutic effects.
• Convenient Dosing Schedule: Extended half-life enables once- or twice-weekly administration, reducing dosing frequency compared to bromocriptine.
• Enhanced Tolerability: Lower incidence of gastrointestinal and neurological side effects, promoting better patient adherence.

Can be Prescribed by:
• Endocrinology
• Gynecology
• Reproductive Medicine / Infertility
• Neurology (for pituitary adenomas management)
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.